BioMerieux Other Current Assets 2017-2024 | BMXMF

BioMerieux other current assets from 2017 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • BioMerieux other current assets for the quarter ending December 31, 2024 were $0M, a 100% decline year-over-year.
  • BioMerieux other current assets for 2024 were $0B, a 0% decline from 2023.
  • BioMerieux other current assets for 2023 were $0B, a 0% decline from 2022.
  • BioMerieux other current assets for 2022 were $0B, a 100% decline from 2021.
BioMerieux Annual Other Current Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $9
2020 $0
2019 $0
2018 $0
2017 $2
2016 $0
2015 $0
BioMerieux Quarterly Other Current Assets
(Millions of US $)
2024-12-31
2023-12-31
2023-06-30
2022-12-31
2022-06-30 $8
2021-12-31 $9
2021-06-30
2020-12-31
2019-12-31
2019-06-30
2018-12-31 $0
2018-06-30 $1
2017-12-31 $2
2017-06-30
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $16.861B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.524B 26.54
CVS Health (CVS) United States $81.417B 10.12
Elevance Health (ELV) United States $76.834B 9.91
Cencora (COR) United States $57.577B 20.03
DiDi Global (DIDIY) China $25.180B 26.75
Natera (NTRA) United States $21.599B 0.00
Labcorp Holdings (LH) United States $20.908B 16.96
EUROFINS SCIENT (ERFSF) Luxembourg $13.318B 0.00
CochLear (CHEOY) Australia $13.009B 0.00
Solventum (SOLV) United States $12.815B 13.57
ICON (ICLR) Ireland $12.075B 11.23
Revvity (RVTY) United States $11.607B 19.97
Viatris (VTRS) United States $10.727B 3.69
Medpace Holdings (MEDP) United States $9.208B 24.45
Avantor (AVTR) United States $9.009B 13.09
Sonic Healthcare (SKHHY) Australia $8.842B 0.00
HealthEquity (HQY) United States $8.418B 36.87
Charles River Laboratories (CRL) United States $7.762B 15.21
Caris Life Sciences,�Inc (CAI) United States $7.052B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.840B 28.50
BrightSpring Health Services (BTSG) United States $3.571B 32.76
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.880B 37.45
Alignment Healthcare (ALHC) United States $2.651B 0.00
Concentras Parent (CON) United States $2.593B 14.98
Organon (OGN) United States $2.550B 2.71
GeneDx Holdings (WGS) United States $2.351B 90.54
Ardent Health (ARDT) United States $2.073B 8.84
Progyny (PGNY) United States $2.012B 44.28
PACS (PACS) United States $1.966B 0.00
Premier (PINC) United States $1.750B 13.28
GoodRx Holdings (GDRX) United States $1.725B 34.50
Teladoc Health (TDOC) United States $1.451B 0.00
Establishment Labs Holdings (ESTA) $1.316B 0.00
Pediatrix Medical (MD) United States $1.131B 8.60
CareDx (CDNA) United States $1.115B 17.41
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.931B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.791B 7.41
Nutex Health (NUTX) United States $0.645B 9.76
Embecta (EMBC) United States $0.606B 4.08
InnovAge Holding (INNV) United States $0.582B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
LifeMD (LFMD) United States $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.487B 0.00
Auna S.A (AUNA) Luxembourg $0.473B 10.65
Omada Health (OMDA) $0.452B 0.00
So-Young (SY) China $0.430B 0.00
Enhabit (EHAB) United States $0.359B 29.50
COMPASS Pathways (CMPS) United Kingdom $0.347B 0.00
Performant Healthcare (PHLT) United States $0.331B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Beauty Health (SKIN) United States $0.236B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.142B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
Ascend Wellness Holdings (AAWH) United States $0.078B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Basel Medical Group (BMGL) Singapore $0.056B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
OSR Holdings (OSRH) United States $0.022B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00